A Clinical Study of Intravenous Immunoglobulin

NCT00468273 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

57

Enrollment

INDUSTRY

Sponsor class

Conditions

Immunologic Deficiency Syndromes

Interventions

DRUG: Immune Globulin Intravenous (Human) Omr-IgG-am IGIV

Sponsor

FFF Enterprises

Collaborators

[object Object]